Maldives vs Somalia: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Maldives
2.0%
in 2025
Somalia
20.0%
in 2025
Maldives rank
164th
Somalia rank
162nd
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Maldives
- Somalia
How they compare
Somalia currently reports 20.0% against 2.0% in Maldives, a difference of 18.0%.
That makes Somalia's figure about 10.0 times Maldives's.
Across all 18 years both countries report, Somalia has been ahead every year.
Maldives ranks 164th and Somalia ranks 162nd of 192 countries.
Somalia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Maldives | Somalia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 0.0% | 0.0% | 0.0% | — |
| 2020s | 0.3% | 3.3% | 3.0% | Somalia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Maldives or Somalia?
- Somalia, at 20.0% against 2.0% in Maldives as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Maldives and Somalia?
- 18.0%, with Somalia ahead.
- How many years of comparable data are there for Maldives and Somalia?
- 18 years are reported by both, from 2008 to 2025.
- How do Maldives and Somalia rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Maldives ranks 164th and Somalia ranks 162nd of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.